Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Carbohydrates, glycemic index and diabetes mellitus

Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals

Abstract

BACKGROUND/OBJECTIVES:

Lipid accumulation product (LAP) is an index, which combines waist circumference (WC) and triglyceride (TG) reflecting lipid accumulation. The aims of the study were to explore the relationship between LAP and insulin resistance (IR) and to assess whether LAP was superior to WC and body mass index (BMI) in identifying IR.

SUBJECTS/METHODS:

The study was cross-sectional and included 2524 non-diabetic subjects from China. The blood pressure (BP), anthropometric measurements, glucose levels, insulin levels and a fasting lipid profile were measured. BMI, the homeostasis model assessment of IR (HOMA-IR) and LAP were calculated.

RESULTS:

In both sexes, BP, BMI, total cholesterol (TC), non high-density lipoprotein cholesterol (non-HDL-C), HOMA-IR, fasting and postprandial glucose levels increased across LAP quartiles (P<0.001), while HDL cholesterol (HDL-C) levels decreased across LAP quartiles (P<0.001). Pearson’s correlation analysis demonstrated that HOMA-IR was correlated with LAP, BMI, WC, TG, HDL-C and non-HDL-C in both sexes (P<0.001). Multivariate analysis demonstrated that LAP had a greater impact on HOMA-IR than BMI and WC.

CONCLUSIONS:

LAP is closely associated with HOMA-IR and is a powerful index that outperforms BMI and WC in identifying IR in non-diabetic individuals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kriketos AD, Furler SM, Gan SK, Poynten AM, Chisholm DJ, Campbell LV . Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. J Clin Endocrinol Metab 2003; 88: 793–798.

    Article  CAS  Google Scholar 

  2. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039–1049.

    Article  Google Scholar 

  3. Boden G . Obesity and free fatty acids. Endocrinol Metab Clin Norht Am 2008; 37: 635–646.

    Article  CAS  Google Scholar 

  4. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 2007; 120 (2 Suppl.1), S3–S8.

    Article  CAS  Google Scholar 

  5. Scaglione R, Di Chiara T, Cariello T, Licata G . Visceral obesity and metabolic syndrome: two faces of the same medal? Intern Emerg Med 2010; 5: 111–119.

    Article  Google Scholar 

  6. Lewanczuk RZ, Paty BW, Toth EL . Comparison of the [13C] glucose breath test to the hyperinsulinemic–euglycemic clampwhen determining insulin resistance. Diabetes Care 2004; 27: 441–447.

    Article  Google Scholar 

  7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  Google Scholar 

  8. Bozorgmanesh M, Hadaegh F, Azizi F . Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010; 9: 45.

    Article  Google Scholar 

  9. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayma S et al. Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis 2011; 10: 79.

    Article  CAS  Google Scholar 

  10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.

    Article  CAS  Google Scholar 

  11. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003; 52: 172–179.

    Article  CAS  Google Scholar 

  12. Kahn HS . The ‘lipid accumulation product’ performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005; 5: 26.

    Article  Google Scholar 

  13. Wiltgen D, Benedetto IG, Mastella LS, Spirtzer PM . Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009; 24: 1726–1731.

    Article  CAS  Google Scholar 

  14. Taverna MJ, Martinez-Larrad MT, Frechtel GD, Serrano-Rios M . Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 2011; 164: 559–567.

    Article  CAS  Google Scholar 

  15. Ran XW, Li XS, Tong NW, Li QF, Tang BD, Li JX . Body fat distribution: its characteristic and relationship to cardiovascular risk factors in obese Chinese. J Sichuan Univ (Med Sci Edi) 2004; 35: 699–703. (in Chinese).

    CAS  Google Scholar 

  16. Bressler P, Bailey S, Matsuda M, DeFronzo RA . Insulin resistance and coronary artery disease. Diabetologia 1996; 39: 1345–1350.

    Article  CAS  Google Scholar 

  17. Choi SH, Ginsberg HN . Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab 2011; 22: 353–363.

    Article  Google Scholar 

  18. Sam S, Haffner S, Davidson MH, D′Agostino RB, Feinstein S, Kondos G et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care 2009; 32: 1916–1920.

    Article  CAS  Google Scholar 

  19. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179–184.

    Article  CAS  Google Scholar 

  20. St-Pierre J, Lemieux I, Vohl M, Perron P, Tremblay G, Despres J et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardio 2002; l90: 15–18.

    Article  Google Scholar 

  21. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynold RF et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398–1405.

    Article  Google Scholar 

  22. Gu D, Reynolds K, Yang W, Chenn Wu X, Duan X et al. The prevalence of metabolic syndrome in the general adult population aged 35–74 years in China. Chin J Diabetes 2005; 13: 181–186.

    Google Scholar 

  23. Després JP, Cartier A, Côté M, Arsenault BJ . The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Ann Med 2008; 40: 514–523.

    Article  Google Scholar 

  24. Kraegen EW, Cooney GJ, Ye J . Thompson. Triglycerides, fatty acids and insulin resistance—hyperinsulinemia. Exp Clin Endocrinol Diabetes 2001; 109: S516–S526.

    Article  CAS  Google Scholar 

  25. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 2001; 98: 7522–7527.

    Article  CAS  Google Scholar 

  26. Kahn HS . The lipid accumulation product is better than BMI for identifying diabetes. Diabetes Care 2006; 29: 151–153.

    Article  Google Scholar 

Download references

Acknowledgements

This research was supported by Natural Science Foundation Project of Chongqing CSTC(No.2009BB5076).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Li.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, C., Li, R., Zhang, S. et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr 66, 1035–1038 (2012). https://doi.org/10.1038/ejcn.2012.83

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2012.83

Keywords

This article is cited by

Search

Quick links